AAPL299.77+1.76 (+0.59%) ▲|ABBV230.63+14.14 (+6.53%) ▲|ABT87.83-0.59 (-0.66%) ▼|ACN121.53-6.45 (-5.04%) ▼|ADBE193.54-1.63 (-0.83%) ▼|AMAT627.06+9.95 (+1.61%) ▲|AMD546.40+9.03 (+1.68%) ▲|AMGN342.18+4.58 (+1.36%) ▲|AMT177.24+1.19 (+0.68%) ▲|AMZN233.57-10.82 (-4.43%) ▼|AVGO394.92-16.43 (-3.99%) ▼|AXP337.15-0.86 (-0.25%) ▼|BA221.59-1.13 (-0.51%) ▼|BAC57.41+1.21 (+2.14%) ▲|BKNG165.27-6.51 (-3.79%) ▼|BLK1,050.06-0.03 (0.00%) ▼|BMY54.35+0.35 (+0.64%) ▲|BNY145.88+2.25 (+1.56%) ▲|BRK-B490.10+0.64 (+0.13%) ▲|C145.74+2.68 (+1.87%) ▲|CAT1,016.41+30.59 (+3.10%) ▲|CL90.52+1.04 (+1.16%) ▲|CMCSA22.41-0.03 (-0.11%) ▼|COF199.29-2.24 (-1.11%) ▼|COP109.01+1.27 (+1.18%) ▲|COST950.35-1.10 (-0.12%) ▼|CRM149.09-2.69 (-1.77%) ▼|CSCO121.05+1.51 (+1.26%) ▲|CVS102.59+4.27 (+4.34%) ▲|CVX173.80+0.17 (+0.10%) ▲|DE603.46+14.22 (+2.41%) ▲|DHR175.83-1.34 (-0.76%) ▼|DIS102.88-1.01 (-0.97%) ▼|DUK124.52+0.66 (+0.53%) ▲|EMR150.68+0.02 (+0.01%) ▲|FDX329.82+4.84 (+1.49%) ▲|GD345.22-4.79 (-1.37%) ▼|GE357.640.00 (0.00%) ▼|GEV1,114.95+5.22 (+0.47%) ▲|GILD123.82+0.06 (+0.05%) ▲|GM82.58+3.29 (+4.15%) ▲|GOOG342.22-25.24 (-6.87%) ▼|GOOGL342.77-25.26 (-6.86%) ▼|GS1,094.90-1.66 (-0.15%) ▼|HD329.78-4.50 (-1.35%) ▼|HON231.08+2.07 (+0.90%) ▲|IBM246.19-2.92 (-1.17%) ▼|INTC140.02+6.03 (+4.50%) ▲|INTU258.80-8.20 (-3.07%) ▼|ISRG401.85-4.94 (-1.21%) ▼|JNJ230.89+2.50 (+1.09%) ▲|JPM330.36+5.14 (+1.58%) ▲|KO79.54+0.15 (+0.18%) ▲|LIN512.40+0.25 (+0.05%) ▲|LLY1,098.30-0.27 (-0.02%) ▼|LMT495.22-15.73 (-3.08%) ▼|LOW216.04-6.16 (-2.77%) ▼|LRCX394.19+5.15 (+1.32%) ▲|MA487.65-2.14 (-0.44%) ▼|MCD274.12-4.49 (-1.61%) ▼|MDLZ60.06-0.06 (-0.10%) ▼|MDT78.90-0.44 (-0.55%) ▼|META561.37-15.85 (-2.75%) ▼|MMM162.94+2.34 (+1.45%) ▲|MO69.98+0.86 (+1.24%) ▲|MRK113.73-0.15 (-0.13%) ▼|MS226.88+3.71 (+1.66%) ▲|MSFT371.46-7.94 (-2.09%) ▼|MU1,191.02+57.03 (+5.03%) ▲|NEE87.21+0.46 (+0.53%) ▲|NFLX74.12-3.26 (-4.22%) ▼|NKE43.52-1.68 (-3.72%) ▼|NOW93.18-1.86 (-1.96%) ▼|NVDA209.31-1.38 (-0.66%) ▼|ORCL178.82-5.47 (-2.97%) ▼|PEP141.71-0.31 (-0.22%) ▼|PFE25.11-0.10 (-0.38%) ▼|PG150.08-0.31 (-0.20%) ▼|PLTR122.33-6.14 (-4.78%) ▼|PM175.39-3.01 (-1.69%) ▼|QCOM228.57+2.46 (+1.09%) ▲|RTX181.93-3.67 (-1.98%) ▼|SBUX100.87+0.22 (+0.21%) ▲|SCHW91.86+0.16 (+0.17%) ▲|SO93.80+0.71 (+0.76%) ▲|SPG213.77+2.44 (+1.15%) ▲|T22.37+0.36 (+1.64%) ▲|TMO459.70-4.92 (-1.06%) ▼|TMUS180.80-0.87 (-0.48%) ▼|TSLA408.50+8.01 (+2.00%) ▲|TXN332.07+9.21 (+2.85%) ▲|UBER71.77+0.13 (+0.17%) ▲|UNH405.93+4.97 (+1.24%) ▲|UNP261.35+4.47 (+1.74%) ▲|UPS107.99+3.13 (+2.98%) ▲|USB58.85+0.71 (+1.21%) ▲|V330.32+3.08 (+0.94%) ▲|VZ45.65+0.28 (+0.62%) ▲|WFC83.42+1.22 (+1.48%) ▲|WMT117.70+0.52 (+0.44%) ▲|XOM137.76-0.05 (-0.04%) ▼|AAPL299.77+1.76 (+0.59%) ▲|ABBV230.63+14.14 (+6.53%) ▲|ABT87.83-0.59 (-0.66%) ▼|ACN121.53-6.45 (-5.04%) ▼|ADBE193.54-1.63 (-0.83%) ▼|AMAT627.06+9.95 (+1.61%) ▲|AMD546.40+9.03 (+1.68%) ▲|AMGN342.18+4.58 (+1.36%) ▲|AMT177.24+1.19 (+0.68%) ▲|AMZN233.57-10.82 (-4.43%) ▼|AVGO394.92-16.43 (-3.99%) ▼|AXP337.15-0.86 (-0.25%) ▼|BA221.59-1.13 (-0.51%) ▼|BAC57.41+1.21 (+2.14%) ▲|BKNG165.27-6.51 (-3.79%) ▼|BLK1,050.06-0.03 (0.00%) ▼|BMY54.35+0.35 (+0.64%) ▲|BNY145.88+2.25 (+1.56%) ▲|BRK-B490.10+0.64 (+0.13%) ▲|C145.74+2.68 (+1.87%) ▲|CAT1,016.41+30.59 (+3.10%) ▲|CL90.52+1.04 (+1.16%) ▲|CMCSA22.41-0.03 (-0.11%) ▼|COF199.29-2.24 (-1.11%) ▼|COP109.01+1.27 (+1.18%) ▲|COST950.35-1.10 (-0.12%) ▼|CRM149.09-2.69 (-1.77%) ▼|CSCO121.05+1.51 (+1.26%) ▲|CVS102.59+4.27 (+4.34%) ▲|CVX173.80+0.17 (+0.10%) ▲|DE603.46+14.22 (+2.41%) ▲|DHR175.83-1.34 (-0.76%) ▼|DIS102.88-1.01 (-0.97%) ▼|DUK124.52+0.66 (+0.53%) ▲|EMR150.68+0.02 (+0.01%) ▲|FDX329.82+4.84 (+1.49%) ▲|GD345.22-4.79 (-1.37%) ▼|GE357.640.00 (0.00%) ▼|GEV1,114.95+5.22 (+0.47%) ▲|GILD123.82+0.06 (+0.05%) ▲|GM82.58+3.29 (+4.15%) ▲|GOOG342.22-25.24 (-6.87%) ▼|GOOGL342.77-25.26 (-6.86%) ▼|GS1,094.90-1.66 (-0.15%) ▼|HD329.78-4.50 (-1.35%) ▼|HON231.08+2.07 (+0.90%) ▲|IBM246.19-2.92 (-1.17%) ▼|INTC140.02+6.03 (+4.50%) ▲|INTU258.80-8.20 (-3.07%) ▼|ISRG401.85-4.94 (-1.21%) ▼|JNJ230.89+2.50 (+1.09%) ▲|JPM330.36+5.14 (+1.58%) ▲|KO79.54+0.15 (+0.18%) ▲|LIN512.40+0.25 (+0.05%) ▲|LLY1,098.30-0.27 (-0.02%) ▼|LMT495.22-15.73 (-3.08%) ▼|LOW216.04-6.16 (-2.77%) ▼|LRCX394.19+5.15 (+1.32%) ▲|MA487.65-2.14 (-0.44%) ▼|MCD274.12-4.49 (-1.61%) ▼|MDLZ60.06-0.06 (-0.10%) ▼|MDT78.90-0.44 (-0.55%) ▼|META561.37-15.85 (-2.75%) ▼|MMM162.94+2.34 (+1.45%) ▲|MO69.98+0.86 (+1.24%) ▲|MRK113.73-0.15 (-0.13%) ▼|MS226.88+3.71 (+1.66%) ▲|MSFT371.46-7.94 (-2.09%) ▼|MU1,191.02+57.03 (+5.03%) ▲|NEE87.21+0.46 (+0.53%) ▲|NFLX74.12-3.26 (-4.22%) ▼|NKE43.52-1.68 (-3.72%) ▼|NOW93.18-1.86 (-1.96%) ▼|NVDA209.31-1.38 (-0.66%) ▼|ORCL178.82-5.47 (-2.97%) ▼|PEP141.71-0.31 (-0.22%) ▼|PFE25.11-0.10 (-0.38%) ▼|PG150.08-0.31 (-0.20%) ▼|PLTR122.33-6.14 (-4.78%) ▼|PM175.39-3.01 (-1.69%) ▼|QCOM228.57+2.46 (+1.09%) ▲|RTX181.93-3.67 (-1.98%) ▼|SBUX100.87+0.22 (+0.21%) ▲|SCHW91.86+0.16 (+0.17%) ▲|SO93.80+0.71 (+0.76%) ▲|SPG213.77+2.44 (+1.15%) ▲|T22.37+0.36 (+1.64%) ▲|TMO459.70-4.92 (-1.06%) ▼|TMUS180.80-0.87 (-0.48%) ▼|TSLA408.50+8.01 (+2.00%) ▲|TXN332.07+9.21 (+2.85%) ▲|UBER71.77+0.13 (+0.17%) ▲|UNH405.93+4.97 (+1.24%) ▲|UNP261.35+4.47 (+1.74%) ▲|UPS107.99+3.13 (+2.98%) ▲|USB58.85+0.71 (+1.21%) ▲|V330.32+3.08 (+0.94%) ▲|VZ45.65+0.28 (+0.62%) ▲|WFC83.42+1.22 (+1.48%) ▲|WMT117.70+0.52 (+0.44%) ▲|XOM137.76-0.05 (-0.04%) ▼|
22.8 C
New York
Monday, June 22, 2026

Tag: stage

newssourceFORcompanyinformationcontent1marketreleases

Toobit Adds XLM to Fixed Earn Series with Limited-Time 60% APR

GEORGE TOWN, Cayman Islands, June 08, 2026 (GLOBE NEWSWIRE) -- Toobit, the award-winning global cryptocurrency exchange, today announces the addition of Stellar (XLM) to its high-yield Fixed Earn series, offering traders an opportunity to capture 60% APR on their staked assets.

Carnegie Mellon Alumna Earns Tony Award for Best Musical

CMU alumni recognized with 67 Tonys to date — onstage and behind the scenes NEW YORK and PITTSBURGH, June 8, 2026 /PRNewswire/ -- Carnegie...

Lim Meng Hoong: AI Is Entering a New Era of Scientific Infrastructure, Insights from Science x AI Summit 2026

SAN FRANCISCO, June 07, 2026 (GLOBE NEWSWIRE) -- On May 12, the Science x AI Summit 2026 held in Silicon Valley brought together numerous scientists, AI researchers, and industry institutions. Lim Meng Hoong, founder of MengHoong Intelligent Investment Academy, was invited to participate in the summit and engaged in discussions on the long-term impact of AI on scientific research systems and industrial structures. Unlike previous discussions centered on commercial applications, the summit this year placed greater emphasis on “how AI can drive scientific breakthroughs” and continued to advance international discussions around AI for Science.

The OREO Brand & BTS Movement is On! Introducing the Limited Edition OREO & BTS Cookies

BTS is sharing a taste of their Korean roots through a new OREO cookie they created.The OREO cookie offers a taste of BTS's home...

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 7, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 7, 2026 /CNW/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Finnate Listed on PathFin.ai Knowledge Hub under the MAS Pathfinder Programme Following Independent Review and Verification Process

MAS Pathfinder Programme listing reflects Finnate's governance-focused design and real-world deployment maturity across regulated financial servicesMELBOURNE, Australia, June 8, 2026 /PRNewswire/ -- Centelon announced that...

Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while...

Company announcement No. 21 / 2026

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

NEW ORLEANS, June 7, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative...

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

NEW ORLEANS, June 8, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative...

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting...

Ingelheim, Germany - Boehringer Ingelheim today announced positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist survodutide (BI 456906), SYNCHRONIZE-1 and SYNCHRONIZE-MASLD.2,4 The results demonstrate survodutide’s potential to reduce weight and therefore improve metabolic health in two distinct populations: adults living with obesity or overweight, without type 2 diabetes (SYNCHRONIZE-1),2 and adults with overweight or obesity with metabolic dysfunction-associated steatotic liver disease (MASLD) with evidence of inflammation and or fibrosis (SYNCHRONIZE-MASLD).4 Full results from SYNCHRONIZE-1 and SYNCHRONIZE-MASLD were presented today at the American Diabetes Association’s (ADA) 2026 Scientific Sessions and published simultaneously in The New England Journal of Medicine and Nature Medicine respectively.5,6

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage...

In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%)In ATTAIN-2, women taking Foundayo lost significant...

MimiSilk Marks 12 Years of Advanced Care with New Product Launches and Anniversary Sale

MONROE, N.J. and RANCHO CUCAMONGA, Calif., June 7, 2026 /PRNewswire/ -- For 12 years, MimiSilk, the at-home beauty device brand, has remained committed to a single...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStage

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers